Physician profile
Jacqueline Carpenter
NPI 1821382482
$1,634.75
in general payments reported to CMS, 2019-2025
22 companies · $512 in 2025
The $512 reported for 2025 was more than what 81% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64.82 · 2021: $99.58 · 2022: $340 · 2023: $316 · 2024: $302 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,130.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $247.65 | 2022-2025 | Fluent Fluid Management System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Astellas Pharma US INC | $233.90 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $210.47 | 2019-2025 | Slynd, Tyblume |
| Mayne Pharma Commercial LLC | $152.72 | 2022-2025 | |
| Sumitomo Pharma America, INC. | $105.06 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $87.67 | 2021-2022 | |
| Pfizer INC. | $74.35 | 2023-2025 | |
| Gynesonics, INC. | $69.37 | 2022-2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Therapeuticsmd, INC. | $61.22 | 2019-2022 | |
| Agile Therapeutics, INC. | $58.98 | 2022-2023 | Twirla |
| Sage Therapeutics, LLC | $51.81 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $51.58 | 2025 | |
| Millicent US INC | $39.85 | 2024-2025 | Intrarosa, Femlyv |
| Abbvie INC. | $32.19 | 2023 | Lo Loestrin Fe |
| Lupin INC. | $27.18 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $24.12 | 2021 | |
| Mylan Pharmaceuticals INC. | $20.80 | 2022 | |
| Baxter Healthcare | $19.90 | 2025 | Perclot |
| Daiichi Sankyo INC. | $19.68 | 2021 | |
| Shield Therapeutics INC | $17.02 | 2023 | Accrufer |
| Coopersurgical, INC. | $15.23 | 2022 | |
| Avion Pharmaceuticals | $14.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacqueline Carpenter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.